Non Hodgkin’s lymphoma and its association with Hepatitis C (HCV) and Human Immune Deficiency Viruses (HIV) in Sudanese patients

Nagla Gasmelseed, Afrah Awad Elsir, Ahmed Elhaj Mohamed


Background: Lymphomas constitute a heterogeneous group of malignant disorders with different
clinical behaviours, pathological features and epidemiological characteristics. Infections with certain
viruses and bacteria are associated with increased risk for lymphomas.
Objectives: The objective of this study was to identify the association of HCV, HIV and Non Hodgkin’s
lymphoma (NHL) in the Sudanese.
Patients and Methods: A case-control study was conducted at the National Cancer Institute (NCI)
University of Gezira Sudan, during 2007 to 2008. HCV and HIV were detected using polymerase chain
reaction (PCR), in 81 NHL patients (confirmed cytologically and histopathologically) and 95 hospitalbased
controls matched for sex and age. ICT was used as a screening method for both HCV and HIV.
Results: HCV was identified in 3 (3.7%) cases and 3 (3.2%) controls. The difference was not significant.
9/81 (11.1%) cases and 2/95 (2.1%) of the controls were found positive to HIV. The result showed a
significant difference between cases and controls (P<0.05).
Conclusion: HIV infection, but not HCV infection, was associated with non-Hodgkin’s lymphoma in
Sudanese, suggesting a possible role for HIV in the development of non-Hodgkin’s lymphoma.


Non Hodgkin’s; lymphoma and its ;association with ;Hepatitis C (HCV) and; Human; Immune; Deficiency ;Viruses (HIV) in ;Sudanese; patients

Full Text:



Globacan 2008: Cancer Incidence and Mortality

Worldwide. (www.

International Agency for Research on Cancer

(IARC) 2010

Abuidris, D O, Ahmed M E, Elgaili E M, et al.

Childhood cancer in Sudan: 1999-2007. Trop

Doct 2008; 38: 208-10.

de Sanjose, S, Benavente Y, Vajdic C M, et

al. Hepatitis C and non-Hodgkin lymphoma

among 4784 cases and 6269 controls from

the International Lymphoma Epidemiology

Consortium. Clin Gastroenterol Hepatol 2008;


Dal Maso, L, Franceschi S Hepatitis C virus

and risk of lymphoma and other lymphoid

neoplasms: a meta-analysis of epidemiologic

studies. Cancer Epidemiol Biomarkers Prev

; 15: 2078-85.

Bouvard, V, Baan R, Straif K, et al. A review of

human carcinogens--Part B: biological agents.

Lancet Oncol 2009; 10: 321-2.

Goldman, L., Ezzat S, Mokhtar N, et al.

Viral and non-viral risk factors for non-

Hodgkin’s lymphoma in Egypt: heterogeneity

by histological and immunological subtypes.

Cancer Causes Control 2009; 20: 981-7.

Salem, A K Prevalence of HCV among Yemeni

patients with non-Hodgkin’s lymphoma at

AI-Thawra teaching hospital. Gulf J Oncolog

;5: 22-9.

Zignego, A L, Giannelli F, Marrocchi M E, et

al. T(14;18) translocation in chronic hepatitis C

virus infection. Hepatology 2000; 31: 474-9.

Kitay-Cohen, Y, Amiel A, Hilzenrat N, et al.

Bcl-2 rearrangement in patients with chronic

hepatitis C associated with essential mixed

cryoglobulinemia type II. Blood 2000; 96:


Monni, O, Franssila K, Joensuu H, et al.

BCL2 overexpression in diffuse large B-cell

lymphoma. Leuk Lymphoma 1999; 34: 45-52.

Mudawi, H M, Smith H M,Fletcher I A, et

al. Prevalence and common genotypes of

HCV infection in Sudanese patients with

hepatosplenic schistosomiasis. J Med Virol

; 79: 1322-4.

Mudawi, H M, Smith H M, Rahoud S A, et al.

Epidemiology of HCV infection in Gezira state

of central Sudan. J Med Virol 2007; 79: 383-5.

El-Amin HH, Osman EM, Mekki MO,et al.

Hepatitis C virus infection in hemodialysis

patients in Sudan: two centres’ report. Saudi J

Kidney Dis Transpl. 2007;18:101-6

Hjalgrim, H and Engels E A Infectious aetiology

of Hodgkin and non-Hodgkin lymphomas:

a review of the epidemiological evidence. J

Intern Med 2008; 264: 537-48.

Gassmelseed, D E, Nasr A M, Homeida S

M, et al. Prevalence of HIV infection among

pregnant women of the central Sudan. J Med

Virol 2006; 78: 1269-70.

UNAIDS Report on the global AIDS epidemic


Spinelli, J J, Lai A S, Krajden M, et al. Hepatitis

C virus and risk of non-Hodgkin lymphoma in

British Columbia, Canada. Int J Cancer 2008;

: 630-3.

Zucca, E, Roggero E, Maggi-Solca N, et al.

Prevalence of Helicobacter pylori and hepatitis

C virus infections among non-Hodgkin’s

lymphoma patients in Southern Switzerland.

Haematologica 2000; 85: 147-53.

Afrah Awad Elsir, Ahmed Elhaj Mohamed, Nagla Gasmelseed

Muller, A M, Ihorst G, Mertelsmann R, et al.

Epidemiology of non-Hodgkin’s lymphoma

(NHL): trends, geographic distribution, and

etiology. Ann Hematol 2005; 84: 1-12.

Park, B B, Kim J S, Lee Y Y, et al. Clinical

characteristics and outcome for hepatitis C

virus-positive diffuse large B-cell lymphoma.

Leuk Lymphoma 2008; 49: 88-94.

Wang, F, Xu R H, Han B, et al. High incidence

of hepatitis B virus infection in B-cell subtype

non-Hodgkin lymphoma compared with other

cancers. Cancer 2007; 109: 1360-4.

Matsuo, K, Kusano A, Sugumar A, et al. Effect

of hepatitis C virus infection on the risk of

non-Hodgkin’s lymphoma: a meta-analysis of

epidemiological studies. Cancer Sci 2004; 95:


Singer, I O, Cumming R L, and Hogg R B Is

hepatitis C associated with non-Hodgkin’s

lymphoma? Leuk Lymphoma 1997; 26: 633-4.

Franceschi, S, Lise M, Trepo C, et al. Infection

with hepatitis B and C viruses and risk of

lymphoid malignancies in the European

Prospective Investigation into Cancer

and Nutrition (EPIC). Cancer Epidemiol

Biomarkers Prev.2011; 20: 208-14.

Germanidis, G, Haioun C, Pourquier J, et al.

Hepatitis C virus infection in patients with overt

B-cell non-Hodgkin’s lymphoma in a French

centre. Blood 1999; 93: 1778-9.

McColl, M D, Singer I O, Tait R C, et al. The

role of hepatitis C virus in the aetiology of non-

Hodgkins lymphoma--a regional association?

Leuk Lymphoma 1997; 26: 127-30.

Omoti, C E and Adesuwa O N Prevalence of

HIV seropositivity in patients with lymphoid

malignancies in a tertiary centre in southern

Nigeria. Niger J Clin Pract 2009; 12:141-4.

Sasco, A J, Jaquet A, Boidin E, et al. The

challenge of AIDS-related malignancies in sub-

Saharan Africa. PLoS One; 2010;5: e8621.

Newton, R, Grulich A, Beral V, et al. Cancer

and HIV infection in Rwanda. Lancet 1995;

: 1378-9.

Beral, V, Peterman T, Berkelman R, et al. AIDSassociated

non-Hodgkin lymphoma. Lancet

; 337: 805-9.

Sitas, F, Bezwoda W R, Levin V, et al.

Association between human immunodeficiency

virus type 1 infection and cancer in the black

population of Johannesburg and Soweto, South

Africa. Br J Cancer 1997; 75: 1704-7.

Akinsete, I, Akanmu A S, and Okany C C

Spectrum of clinical diseases in HIV-infected

adults at the Lagos University Teaching

Hospital: a five-year experience [1992-1996].

Afr J Med Med Sci 1998; 27: 147-51.

Grulich, A E AIDS-associated non-Hodgkin’s

lymphoma in the era of highly active

antiretroviral therapy. J Acquir Immune Defic

Syndr 1999; 21 :27-30.


  • There are currently no refbacks.

ISSN: 1858-5345